Table 1

Study steps and timeline

Visit numberV1
Screening
V2
baseline/start of treatment
V3V4V5V6
final visit/end of study
Time (days)−7/−307±214±228±242±3
Written informed consentX
Demographic dataX
Vital signs (1)XXXXXX
Measurement of body temperatureXXXXXX
Physical examinationX
Medical history and concomitant diseasesX
Prior and concomitant medication (2)XXXXXX
Urine pregnancy test (3)X
Identification and evaluation of the target lesionX(4)
Photo of the target lesionXXXXX
Measurement of the area of the target lesionXXXXX
Evaluation of the clinical signs of infectionXXXXXX
Cleaning or medication of lesion(s)XXXXXX
Swab collection of the infected target lesionX(5)XX
Study eligibility
(inclusion and exclusion criteria)
XX
RandomisationX
Schedule of oxygen-ozone therapy (6)XXXX
Prescription of oral antibiotic therapy (7)XX
Bacteriological responseXX
Investigator’s global assessmentXX
Laboratory parametersXXX
Assessment of compliance to antibioticsXXXX
Adverse eventsXXXXXX